Article Versions Notes

Jiao Y, Mahmoud SH, Ye C, Luo Y, Huang W-C, Li Q, Zhou S, Song Y, Tsuji M, Martinez-Sobrido L, et al. In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2. Pharmaceutics. 2025; 17(11):1422. https://doi.org/10.3390/pharmaceutics17111422

Jiao, Yang, Sara H. Mahmoud, Chengjin Ye, Yuan Luo, Wei-Chiao Huang, Qinzhe Li, Shiqi Zhou, Yiting Song, Moriya Tsuji, Luis Martinez-Sobrido, and et al. 2025. "In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2" Pharmaceutics 17, no. 11: 1422. https://doi.org/10.3390/pharmaceutics17111422

Jiao, Y., Mahmoud, S. H., Ye, C., Luo, Y., Huang, W.-C., Li, Q., Zhou, S., Song, Y., Tsuji, M., Martinez-Sobrido, L., & Lovell, J. F. (2025). In Vivo Iterative Adjuvant Screening Identifies an Intranasal Vaccine Formulation for Elicitation of Protective Mucosal Immune Responses Against SARS-CoV-2. Pharmaceutics, 17(11), 1422. https://doi.org/10.3390/pharmaceutics17111422